Limits...
Clinical outcomes of helical tomotherapy for super-elderly patients with localized and locally advanced prostate cancer: comparison with patients under 80 years of age.

Okonogi N, Katoh H, Kawamura H, Tamaki T, Kaminuma T, Murata K, Ohkubo Y, Takakusagi Y, Onishi M, Sekihara T, Okazaki A, Nakano T - J. Radiat. Res. (2015)

Bottom Line: There was no significant difference between the two groups in the biochemical relapse-free rates.There was no significant difference between the aged group and the younger group in the cumulative incidence rates of rectal toxicity or urinary toxicity.No patients exhibited Grade 4 or higher toxicity, and all patients improved with conservative therapy.

View Article: PubMed Central - PubMed

Affiliation: Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3-39-22, Showa-machi, Maebashi, Gunma 371-8511, Japan Oncology Center, Hidaka Hospital, 886, Nakao-machi, Takasaki, Gunma 370-0001, Japan.

No MeSH data available.


Related in: MedlinePlus

Cumulative occurrence rates of late Grade 2 or higher rectal and urinary toxicities after TOMO. The solid lines show the cumulative occurrence rates of rectal toxicity, and dashed lines indicate the cumulative occurrence rates of urinary toxicity. Blue lines illustrate rates for patients 80 years and older, and green lines show the rates for patients younger than 80 years old. There was no significant difference in the cumulative incidence rate or rectal or urinary toxicity.
© Copyright Policy - creative-commons
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4628216&req=5

RRV040F2: Cumulative occurrence rates of late Grade 2 or higher rectal and urinary toxicities after TOMO. The solid lines show the cumulative occurrence rates of rectal toxicity, and dashed lines indicate the cumulative occurrence rates of urinary toxicity. Blue lines illustrate rates for patients 80 years and older, and green lines show the rates for patients younger than 80 years old. There was no significant difference in the cumulative incidence rate or rectal or urinary toxicity.

Mentions: Figure 2 shows the cumulative occurrence rates of developing late Grade 2 or higher rectal or urinary toxicity after TOMO. In the aged group, the 3-year cumulative incidences of rectal and urinary toxicity were 13% and 4.8%, respectively. In the younger group, the 3-year cumulative incidence rates of rectal and urinary toxicity were 7.0% and 1.2%, respectively. There was no significant difference between the aged group and the younger group in either cumulative incidence rates of rectal toxicity or urinary toxicity.Fig. 2.


Clinical outcomes of helical tomotherapy for super-elderly patients with localized and locally advanced prostate cancer: comparison with patients under 80 years of age.

Okonogi N, Katoh H, Kawamura H, Tamaki T, Kaminuma T, Murata K, Ohkubo Y, Takakusagi Y, Onishi M, Sekihara T, Okazaki A, Nakano T - J. Radiat. Res. (2015)

Cumulative occurrence rates of late Grade 2 or higher rectal and urinary toxicities after TOMO. The solid lines show the cumulative occurrence rates of rectal toxicity, and dashed lines indicate the cumulative occurrence rates of urinary toxicity. Blue lines illustrate rates for patients 80 years and older, and green lines show the rates for patients younger than 80 years old. There was no significant difference in the cumulative incidence rate or rectal or urinary toxicity.
© Copyright Policy - creative-commons
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4628216&req=5

RRV040F2: Cumulative occurrence rates of late Grade 2 or higher rectal and urinary toxicities after TOMO. The solid lines show the cumulative occurrence rates of rectal toxicity, and dashed lines indicate the cumulative occurrence rates of urinary toxicity. Blue lines illustrate rates for patients 80 years and older, and green lines show the rates for patients younger than 80 years old. There was no significant difference in the cumulative incidence rate or rectal or urinary toxicity.
Mentions: Figure 2 shows the cumulative occurrence rates of developing late Grade 2 or higher rectal or urinary toxicity after TOMO. In the aged group, the 3-year cumulative incidences of rectal and urinary toxicity were 13% and 4.8%, respectively. In the younger group, the 3-year cumulative incidence rates of rectal and urinary toxicity were 7.0% and 1.2%, respectively. There was no significant difference between the aged group and the younger group in either cumulative incidence rates of rectal toxicity or urinary toxicity.Fig. 2.

Bottom Line: There was no significant difference between the two groups in the biochemical relapse-free rates.There was no significant difference between the aged group and the younger group in the cumulative incidence rates of rectal toxicity or urinary toxicity.No patients exhibited Grade 4 or higher toxicity, and all patients improved with conservative therapy.

View Article: PubMed Central - PubMed

Affiliation: Department of Radiation Oncology, Gunma University Graduate School of Medicine, 3-39-22, Showa-machi, Maebashi, Gunma 371-8511, Japan Oncology Center, Hidaka Hospital, 886, Nakao-machi, Takasaki, Gunma 370-0001, Japan.

No MeSH data available.


Related in: MedlinePlus